|Mr. Anthony Fernando||Pres, CEO & Director||508.93k||N/A||1972|
|Mr. Todd M. Pope||Sr. Advisor||839.13k||2.02M||1965|
|Mr. Joseph P. Slattery CPA, CPA||Consultant||515.23k||1.97M||1965|
|Mr. Eric A. Smith||Chief Commercial Officer||370.53k||N/A||1972|
|Mr. Brett Farabaugh||Interim Chief Financial Officer||N/A||N/A||1968|
TransEnterix, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery. The company offers Senhance System, a multi-port robotic surgery system, which allows up to four arms to control robotic instruments and a camera in Europe. It also provides SurgiBot System, a single-port system robotically enhanced laparoscopic surgical platform. TransEnterix, Inc. is headquartered in Morrisville, North Carolina.
TransEnterix, Inc.’s ISS Governance QualityScore as of December 2, 2019 is 7. The pillar scores are Audit: 2; Board: 7; Shareholder Rights: 2; Compensation: 10.